{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:19Z","timestamp":1783606939564,"version":"3.55.0"},"reference-count":66,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:p>Neuroendocrine tumours (NETs) are heterogeneous, biologically variable tumours arising from the diffuse neuroendocrine system. While more frequently seen in older patients, the incidence and prevalence of NETs in the younger population are increasing. In addition, because of their generally slow progression and favourable prognosis, coupled with widely available effective treatments, survival times even with metastatic tumours may often be prolonged. However, there is a paucity of data on the effect of treatment of NETs on men\u2019s and women\u2019s reproductive and sexual health. In this review, we have evaluated the effects of NET therapies, including somatostatin analogues (SSTAs), molecular targeted therapy (everolimus and sunitinib), peptide receptor radionuclide therapy (PRRT), and chemotherapy, on reproductive and sexual function in patients with NETs. There is a lack of evidence on the detrimental effects of SSTAs on human fertility, and indeed, many patients have conceived successfully after many years of treatment with SSTAs. Even patients who have received SSTAs during pregnancy have generally shown positive maternal and fetal outcomes. While the effects of PRRT and molecular targeted therapy on fertility are as yet poorly defined, chemotherapy has a proven negative impact on fertility; thus, family and pregnancy planning are strongly recommended before the initiation of chemotherapy. Finally, data on the effects of NET treatment on sexual function are very limited; however, neuroendocrine tumours can express oestrogen receptors\/progesterone receptors (ER\/PR) or testosterone receptors (TR); thus, checking tumour tissue for ER\/PR\/TR status prior to considering hormonal therapy for sexual dysfunction should be considered but warrants additional studies.<\/jats:p>","DOI":"10.1530\/erc-25-0500","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:06:42Z","timestamp":1775066802000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Reproductive and sexual sequelae of neuroendocrine tumour therapies: an under-recognised challenge"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7884-0403","authenticated-orcid":true,"given":"Kalyan Mansukhbhai","family":"Shekhda","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3516-9992","authenticated-orcid":false,"given":"Preet Mukesh","family":"Shah","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5918-4007","authenticated-orcid":false,"given":"Aiyappa","family":"Biddanda","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-6186","authenticated-orcid":true,"given":"Ashley","family":"Grossman","sequence":"additional","affiliation":[{"name":"1"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-1352","authenticated-orcid":false,"given":"Martyn","family":"Caplin","sequence":"additional","affiliation":[{"name":"1"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2026070909453369700_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026070909453369700_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13465","article-title":"Neuroendocrine tumours and pregnancy: real-world data from an European neuroendocrine Tumour Centre of Excellence","volume":"37","author":"Ratnayake","year":"2025","journal-title":"J Neuroendocrinol"},{"key":"2026070909453369700_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2350\/09-04-0635-CP.1","article-title":"Neuroendocrine tumors and tumor syndromes in childhood","volume":"13","author":"Gaal","year":"2010","journal-title":"Pediatr Dev Pathol"},{"key":"2026070909453369700_bib4","doi-asserted-by":"crossref","DOI":"10.15620\/cdc\/158789","article-title":"Births in the United States, 2023","volume-title":"NCHS Data Brief","author":"Martin","year":"2024"},{"key":"2026070909453369700_bib5","first-page":"1","article-title":"Mean age of mothers is on the rise: United States, 2000\u20132014","volume":"232","author":"Mathews","year":"2016","journal-title":"NCHS Data Brief"},{"key":"2026070909453369700_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"2026070909453369700_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000443612","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): results of long-term survival","volume":"104","author":"Rinke","year":"2017","journal-title":"Neuroendocrinology"},{"key":"2026070909453369700_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2265.2004.02098.x","article-title":"Inhibition of endothelial proliferation by the somatostatin analogue SOM230","volume":"61","author":"Adams","year":"2004","journal-title":"Clin Endocrinol"},{"key":"2026070909453369700_bib9","article-title":"Octreotide infusion pump in patients with functional neuroendocrine tumors and refractory hormonal syndrome","volume":"5","author":"Shekhda","year":"2025","journal-title":"Endocr Oncol"},{"key":"2026070909453369700_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2026070909453369700_bib11","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1210\/clinem\/dgaa760","article-title":"Quality of life in patients with neuroendocrine neoplasms: the role of severity, clinical heterogeneity, and resilience","volume":"106","author":"Scandurra","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909453369700_bib12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/cancers14061428","article-title":"Health-related quality of life (HRQoL) in neuroendocrine tumors: a systematic review","volume":"14","author":"Gosain","year":"2022","journal-title":"Cancers"},{"key":"2026070909453369700_bib13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2471\/BLT.24.291565","article-title":"Associations between sexual health and well-being: a systematic review","volume":"102","author":"Vasconcelos","year":"2024","journal-title":"Bull World Health Organ"},{"key":"2026070909453369700_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0959-8049(01)00448-8","article-title":"Quality of life research within the EORTC \u2013 the EORTC QLQ-C30","volume":"38","author":"Fayers","year":"2002","journal-title":"Eur J Cancer"},{"key":"2026070909453369700_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pharmthera.2015.05.007","article-title":"Therapeutic uses of somatostatin and its analogues: current view and potential applications","volume":"152","author":"Rai","year":"2015","journal-title":"Pharmacol Ther"},{"key":"2026070909453369700_bib16","volume-title":"StatPearls [Internet]","author":"O\u2019Toole","year":"2025"},{"key":"2026070909453369700_bib17","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1185\/03007990903328959","article-title":"From somatostatin to octreotide LAR: evolution of a somatostatin analogue","volume":"25","author":"Anthony","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"2026070909453369700_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/npep.2001.0848","article-title":"Cellular biology of somatostatin receptors","volume":"35","author":"Csaba","year":"2001","journal-title":"Neuropeptides"},{"key":"2026070909453369700_bib19","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1095\/biolreprod65.6.1732","article-title":"Somatostatin inhibits stem cell factor messenger RNA expression by Sertoli cells and stem cell factor-induced DNA synthesis in isolated seminiferous tubules","volume":"65","author":"Goddard","year":"2001","journal-title":"Biol Reprod"},{"key":"2026070909453369700_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jsbmb.2013.06.007","article-title":"Somatostatin and its receptors: functional regulation in the development of mice Sertoli cells","volume":"138","author":"Riaz","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070909453369700_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1055\/s-0032-1314859","article-title":"Differential expression of somatostatin receptor subtype 1\u20135 proteins in numerous human normal tissues","volume":"120","author":"Unger","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026070909453369700_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12149-025-02040-9","article-title":"Physiological bio-distribution of 68Ga-DOTA-TATE in pediatric patients","volume":"39","author":"Filizoglu","year":"2025","journal-title":"Ann Nucl Med"},{"key":"2026070909453369700_bib23","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.3390\/jcm11143983","article-title":"Effect of neuroendocrine neoplasm treatment on human reproductive health and sexual function","volume":"11","author":"Zamponi","year":"2022","journal-title":"J Clin Med"},{"key":"2026070909453369700_bib24","first-page":"240","article-title":"Pregnant with metastatic neuroendocrine tumour of the ovary: what now?","volume":"6","author":"Pistilli","year":"2012","journal-title":"Ecancermedicalscience"},{"key":"2026070909453369700_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.31689\/rmm.2025.32.2.193","article-title":"A multidisciplinary approach to managing carcinoid syndrome in pregnant women: ensuring maternal and fetal safety trough interdisciplinary collaboration","volume":"32","author":"Constantin","year":"2025","journal-title":"Medicina Moderna Mod Med"},{"key":"2026070909453369700_bib26","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909453369700_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231186041","article-title":"HORMONET: a phase II trial of tamoxifen for estrogen\/progesterone receptor-positive neuroendocrine tumors","volume":"15","author":"Barros","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"2026070909453369700_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ejendo\/lvae163","article-title":"Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors","volume":"192","author":"Wang","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"2026070909453369700_bib29","volume-title":"Octreotide","author":"Drugs and Lactation Database (LactMed\u00ae) [Internet]","year":"2006"},{"key":"2026070909453369700_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177 Lu-Dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"2026070909453369700_bib31","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/RLU.0000000000001457","article-title":"The impact of radiological response to peptide receptor radionuclide therapy on overall survival in patients with metastatic midgut neuroendocrine tumors","volume":"42","author":"Yalchin","year":"2017","journal-title":"Clin Nucl Med"},{"key":"2026070909453369700_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00259-015-3190-7","article-title":"Long-term results of PRRT in advanced bronchopulmonary carcinoid","volume":"43","author":"Mariniello","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909453369700_bib33","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s00259-009-1151-8","article-title":"Effects of therapy with [177Lu-DOTA0,Tyr3]octreotate on endocrine function","volume":"36","author":"Teunissen","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909453369700_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/RLU.0000000000002267","article-title":"Pregnancy and delivery after PRRT without sequelae","volume":"43","author":"Zhang","year":"2018","journal-title":"Clin Nucl Med"},{"key":"2026070909453369700_bib35","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1007\/s00259-025-07247-6","article-title":"Molecular radiotherapy for adult type metastatic neuroendocrine tumours in children","volume":"24","author":"Peet","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909453369700_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11864-020-0711-9","article-title":"Patient selection and toxicities of PRRT for metastatic neuroendocrine tumors and research opportunities","volume":"21","author":"Shaheen","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"2026070909453369700_bib37","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00259-011-1902-1","article-title":"Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I\u2013II study","volume":"38","author":"Bodei","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909453369700_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2214\/AJR.19.21123","article-title":"Therapy with 177 Lu-DOTATATE: clinical implementation and impact on care of patients with neuroendocrine tumors","volume":"213","author":"Kendi","year":"2019","journal-title":"Am J Roentgenol"},{"key":"2026070909453369700_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13669-021-00310-7","article-title":"Anti-M\u00fcllerian hormone: current understanding and clinical use","volume":"10","author":"Gordon","year":"2021","journal-title":"Curr Obstet Gynecol Rep"},{"key":"2026070909453369700_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/nop\/npw005","article-title":"Fertility preservation in primary brain tumor patients","volume":"4","author":"Stone","year":"2017","journal-title":"Neuro Oncol Pract"},{"key":"2026070909453369700_bib41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10815-013-9999-8","article-title":"Effect of temozolomide on male gametes: an epigenetic risk to the offspring?","volume":"30","author":"Berthaut","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2026070909453369700_bib42","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2022.3","article-title":"Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans","volume":"24","author":"Naren","year":"2022","journal-title":"Expert Rev Mol Med"},{"key":"2026070909453369700_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12094-021-02699-2","article-title":"Multidisciplinary consensus on the criteria for fertility preservation in cancer patients","volume":"24","author":"Santaballa","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"2026070909453369700_bib44","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/life13051209","article-title":"The impact of systemic oncological treatments on the fertility of adolescents and young adults-a systematic review","volume":"13","author":"Himpe","year":"2023","journal-title":"Life"},{"key":"2026070909453369700_bib45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12885-016-2505-9","article-title":"Etoposide damages female germ cells in the developing ovary","volume":"16","author":"Stefansdottir","year":"2016","journal-title":"BMC Cancer"},{"key":"2026070909453369700_bib46","doi-asserted-by":"crossref","first-page":"S778","DOI":"10.21037\/tcr.2016.10.90","article-title":"A new fertility risk rating system for surgical, radiotherapy, and chemotherapy interventions used in testicular cancer","volume":"5","author":"Walter","year":"2016","journal-title":"Transl Cancer Res"},{"key":"2026070909453369700_bib47","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3109\/10428194.2015.1118476","article-title":"Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas","volume":"57","author":"Gharwan","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"2026070909453369700_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2022.812053","article-title":"Irinotecan (CPT-11) treatment induces mild gonadotoxicity","volume":"4","author":"Levi","year":"2022","journal-title":"Front Reprod Health"},{"key":"2026070909453369700_bib49","doi-asserted-by":"crossref","DOI":"10.2196\/44825","article-title":"Fertility preservation techniques in neuro-oncology patients: protocol for a systematic review","volume":"12","author":"Osborne-Grinter","year":"2023","journal-title":"JMIR Res Protoc"},{"key":"2026070909453369700_bib50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1432-2277.2006.00423.x","article-title":"Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview","volume":"20","author":"Huyghe","year":"2007","journal-title":"Transpl Int"},{"key":"2026070909453369700_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152872","article-title":"The tyrosine kinase inhibitor sunitinib affects ovulation but not ovarian reserve in mouse: a preclinical study","volume":"11","author":"Bernard","year":"2016","journal-title":"PLoS One"},{"key":"2026070909453369700_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102131","article-title":"New insights of target therapy: effects of tyrosine kinase inhibitors on Male gonadal function: a systematic review","volume":"22","author":"Marino","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"2026070909453369700_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/crst.crst_9_23","article-title":"Cabozantinib: a narrative drug review","volume":"6","author":"Srigadha","year":"2023","journal-title":"Cancer Res Stat Treat"},{"key":"2026070909453369700_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/17843286.2018.1476115","article-title":"Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies","volume":"74","author":"Bastin","year":"2019","journal-title":"Acta Clin Belg"},{"key":"2026070909453369700_bib58","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jgo.2019.08.003","article-title":"How (and why) to ask the older cancer patient about sexual health and sexual minority status","volume":"11","author":"Cathcart-Rake","year":"2020","journal-title":"J Geriatr Oncol"},{"key":"2026070909453369700_bib59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1743-6109.2009.01620.x","article-title":"Cancer and sexual problems","volume":"7","author":"Sadovsky","year":"2010","journal-title":"J Sex Med"},{"key":"2026070909453369700_bib60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"key":"2026070909453369700_bib61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2190\/PM.40.2.c","article-title":"It\u2019s not over when it\u2019s over: long-term symptoms in cancer survivors \u2013 a systematic review","volume":"40","author":"Harrington","year":"2010","journal-title":"Int J Psychiatr Med"},{"key":"2026070909453369700_bib62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2013.10.015","article-title":"Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study","volume":"132","author":"Zaid","year":"2014","journal-title":"Gynecol Oncol"},{"key":"2026070909453369700_bib63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000178754","article-title":"Sexual function in patients with metastatic midgut carcinoid tumours","volume":"89","author":"der Horst-Schrivers Ana","year":"2009","journal-title":"Neuroendocrinology"},{"key":"2026070909453369700_bib64","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000494293","article-title":"Health-related quality of life in patients with small intestine neuroendocrine tumors","volume":"107","author":"Karppinen","year":"2018","journal-title":"Neuroendocrinology"},{"key":"2026070909453369700_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s42000-018-0037-1","article-title":"A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction","volume":"17","author":"Defeudis","year":"2018","journal-title":"Hormones"},{"key":"2026070909453369700_bib66","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.revmed.2016.07.009","article-title":"Tumeur carcino\u00efde ovarienne responsable d\u2019une \u00e9rythrose faciale permanente et de flushs au d\u00e9cours des co\u00efts","volume":"37","author":"Talvande","year":"2016","journal-title":"Rev Med Interne"},{"key":"2026070909453369700_bib67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jsxm.2020.02.005","article-title":"What is a \u201cvalidated questionnaire\u201d? A critical review of erectile function assessment","volume":"17","author":"Yafi","year":"2020","journal-title":"J Sex Med"},{"key":"2026070909453369700_bib68","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJMcp2313307","article-title":"Sexual dysfunction in women","volume":"391","author":"Davis","year":"2024","journal-title":"N Engl J Med"},{"key":"2026070909453369700_bib69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1743-6109.2009.01619.x","article-title":"Recommendations for the clinical evaluation of men and women with sexual dysfunction","volume":"7","author":"Hatzichristou","year":"2010","journal-title":"J Sex Med"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/4\/ERC-25-0500.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/4\/ERC-25-0500.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0500\/503036\/erc-25-0500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0500\/503036\/erc-25-0500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:45:50Z","timestamp":1783604750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/4\/e250500\/75558\/Reproductive-and-sexual-sequelae-of-neuroendocrine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0500","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"e250500"}}